Scientists seek to tame cancer Drug's harsh side effects
NCT ID NCT07490509
Summary
This study aims to understand why a powerful breast cancer drug, abemaciclib, causes severe diarrhea and low white blood cell counts in many patients. Researchers will measure drug levels in the blood of 235 patients to see if these side effects are linked to how much of the drug is in their system. The goal is to find a way to adjust the dose to reduce these side effects so patients can stay on this effective treatment longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.